TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

bull
Play
JIM CRAMER

Individual Investors Are Back: Cramer's 'Mad Money' Recap (Monday 12/7/20)

  • By Scott Rutt
  • Dec 7, 2020 7:54 PM EST
bull
JIM CRAMER

Individual Investors Are Back: Cramer's 'Mad Money' Recap (Monday 12/7/20)

  • By Scott Rutt
  • Dec 7, 2020 7:54 PM EST
PRESS RELEASES

Acadia Pharmaceuticals To Present At The Stifel 2020 Virtual Healthcare Conference On November 17, 2020

  • By Business Wire
  • Nov 10, 2020 9:00 AM EST
PRESS RELEASES

Acadia Pharmaceuticals To Present New Scientific Data On Pimavanserin In Neurodegenerative Diseases At The 13th Clinical Trials On Alzheimer's Disease (CTAD) Conference

  • By Business Wire
  • Oct 26, 2020 9:00 AM EDT
PRESS RELEASES

Acadia Pharmaceuticals To Announce Third Quarter 2020 Financial Results On November 4, 2020

  • By Business Wire
  • Oct 21, 2020 4:05 PM EDT
PRESS RELEASES

The Lewy Body Dementia Association And Acadia Pharmaceuticals To Release Educational Version Of The Highly Acclaimed Robin Williams Documentary, "Robin's Wish"

  • By Business Wire
  • Oct 14, 2020 4:05 PM EDT
PRESS RELEASES

Dr. Elizabeth Garofalo (Photo: Business Wire)

  • By Business Wire
  • Oct 1, 2020 9:00 AM EDT
PRESS RELEASES

(ACAD) Alert: Johnson Fistel Announces Shareholder Class Action Against ACADIA Pharmaceuticals Survives Motion To Dismiss; Should Management Be Held Accountable For Investors Losses?

  • By PR Newswire
  • Sep 5, 2020 8:47 AM EDT
PRESS RELEASES

ACADIA Pharmaceuticals To Present At Upcoming Investor Conferences

  • By Business Wire
  • Sep 2, 2020 9:00 AM EDT
PRESS RELEASES

Gudarz Davar, M.D., Executive Vice President And Head Of Research And Development (Photo: Business Wire)

  • By Business Wire
  • Aug 31, 2020 9:00 AM EDT
PRESS RELEASES

ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program To Portfolio

  • By Business Wire
  • Aug 25, 2020 9:00 AM EDT
PRESS RELEASES

ACADIA Pharmaceuticals To Present At The JMP Securities CNS Forum On August 19, 2020

  • By Business Wire
  • Aug 12, 2020 9:00 AM EDT
PRESS RELEASES

People With Dementia And Caregivers Share The Significant Burden Of Visual Hallucinations And Paranoid Delusions, New Survey Highlights

  • By Business Wire
  • Jul 29, 2020 9:00 AM EDT
PRESS RELEASES

ACADIA Pharmaceuticals To Announce Second Quarter 2020 Financial Results On August 5, 2020

  • By Business Wire
  • Jul 22, 2020 4:05 PM EDT
Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet
INVESTING

Acadia Depression Drug Misses Key Endpoint in Phase III Trial

  • By Dan Weil
  • Jul 21, 2020 1:12 PM EDT
PRESS RELEASES

ACADIA Pharmaceuticals To Present At The Goldman Sachs 41st Annual Global Healthcare Conference On June 9, 2020

  • By Business Wire
  • Jun 2, 2020 9:00 AM EDT
PRESS RELEASES

ACADIA Pharmaceuticals Appoints Mark Schneyer As Senior Vice President, Business Development And Chief Business Officer

  • By Business Wire
  • May 28, 2020 9:00 AM EDT
PRESS RELEASES

ACADIA Pharmaceuticals And Vanderbilt University Announce Exclusive License Agreement And Research Collaboration

  • By Business Wire
  • May 7, 2020 4:05 PM EDT
PRESS RELEASES

ACADIA Pharmaceuticals To Present At Two Upcoming Virtual Investor Conferences

  • By Business Wire
  • May 5, 2020 4:05 PM EDT
PRESS RELEASES

ACADIA Pharmaceuticals To Announce First Quarter 2020 Financial Results On May 7, 2020

  • By Business Wire
  • Apr 15, 2020 4:05 PM EDT
PRESS RELEASES

ACADIA Pharmaceuticals And Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation For Trofinetide For The Treatment Of Rett Syndrome

  • By Business Wire
  • Mar 3, 2020 5:50 PM EST
PRESS RELEASES

ACADIA Pharmaceuticals To Present At The Cowen And Company 40th Annual Health Care Conference On March 2, 2020

  • By Business Wire
  • Feb 24, 2020 9:00 AM EST
PRESS RELEASES

ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2019 Financial Results On February 26, 2020

  • By Business Wire
  • Feb 12, 2020 9:00 AM EST
Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet
INVESTING

Best Stocks of the Decade: Acadia’s Drug Development Success

  • By Scott Van Voorhis
  • Jan 5, 2020 10:36 PM EST
Lannett Rises After Announcing Adderall Distribution Agreement
STOCKS

Acadia Pharma Jumps on Positive Data From Depression Treatment Candidate

  • By Tony Owusu
  • Sep 23, 2019 11:17 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.